UNSPSC 51273605: Cocaine

This classification denotes a cns stimulant with the molecular formula C17H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I5Y540LHVR, chemically known as 8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))- but generally known as cocaine, which bears US NIH Compound Identifier 5760. European Medicines Agency schedules Cocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13416MIG.

UNSPSC 51273605 Cocaine is a Commodity code that in practice captures state and local procurement of naloxone and drug deactivation systems for community health and harm-reduction initiatives, not controlled substances. The code's nominal scope—pharmaceutical cocaine—does not align with recent solicitation activity. State and local governments are using this code to procure naloxone (a rapid-response overdose reversal agent) and safe drug deactivation systems that support public health emergency response and substance-abuse mitigation. Issuing bodies soliciting under this code include county health departments and county purchasing offices pursuing community health contracts. The work involves annual supply agreements with defined delivery schedules, typically quarterly, and fixed-fee or unit-cost pricing structures.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The contract is an initial two-year term with an optional one-year renewal, and vendors must meet E-Verify compliance, drug-free workplace certification, and specific insurance requirements including workers' compensation and commercial general liability. Recent opportunity data shows limited geographic spread; Florida is the only state with a documented recent solicitation under this code. The mismatch between the code's nominal name and actual procurement activity (harm-reduction supplies rather than controlled drugs) suggests the code may see infrequent or misclassified use in state and local procurement.